Here’s your Investing Action Plan for Wednesday: what you need to know as an investor for the coming day. Biotech stocks Amgen (AMGN) and Gilead Sciences (GILD) report as they also develop Covid-19 drugs. Payment leaders Visa (V) and Mastercard (MA) are also due, while Boeing (BA) eyes another quarter of steep losses.




X



Covid-19 Biotech Stocks To Report

Amgen and Gilead are set to report after the close. Analysts expect Amgen, which hasn’t lately updated progress on its Covid-19 treatment candidate, to post a 2.5% rise in EPS to $3.75 on an 11% hike in sales to $6.38 billion. Gilead is the leading maker of remdesivir, the first Covid-19 treatment granted emergency U.S. approval. But there have been conflicting studies on the drug’s effectiveness. Gilead is seen posting an 4.6% increase in EPS to $1.83, with sales rising 10.6% to $6.2 billion.

Payment Earnings To Continue Slump

Visa and Mastercard both report. Before the open, analysts see Mastercard’s EPS down 23.7% at $1.64 with revenue down 12% at $3.94 billion. After the close, Visa’s fiscal Q4 EPS is seen falling 26% to $1.09 as revenue drops 18% to $5.03 billion. It announced on Oct. 21 that it’s expanding its mobile payments service Visa Tap To Phone to meet global demand for contactless payments.

Boeing To Pile Up More Losses

The aerospace giant will report Q3 results early. Analysts expect a loss of $2.33 per share vs. a profit of $1.45 per share in the year-ago quarter. Revenue is seen falling 31% to $13.81 billion. Boeing said earlier that it had 28 deliveries for Q3, down 55% from a year ago as the 737 Max remains on hold. It has also cut more than 1,000 planes from its backlog this year, and it now stands at 4,325.

E-Commerce Stocks To Report

At eBay (EBAY), the consensus is EPS of 86 cents, up 28%, with revenue up 1.2% to $2.7 billion. It reports late Wednesday, as does Etsy (ETSY). Analysts see Etsy EPS soaring 417% to 62 cents as revenue jumps 111.5% to $418.7 million.

Other Earnings

  • General Electric (GE) reports early and is seen swinging to a loss of 6 cents per share vs. EPS of 15 cents a year ago as revenue falls 18% to $19.15 billion.
  • ServiceNow (NOW) reports late. Analysts expect the enterprise software maker to report EPS of $1.03, up 4%, with revenue climbing 25% to $1.1 billion.
  • UPS (UPS) reports early, and analysts see a 12% EPS decline to $1.82 despite revenue growing 10% to $20.08 billion.
  • Fastly (FSLY) reports late and is seen narrowing per-share losses to 1 cent from 9 cents a share a year ago as revenue grows 42% to $70.6 million.

YOU MAY ALSO LIKE:

Catch The Next Big Winning Stock With MarketSmith

Best Growth Stocks To Buy And Watch

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today

The post Biotechs, Payment, E-Commerce Leaders To Report: Investing Action Plan appeared first on Investor’s Business Daily.

Leave a Reply

Your email address will not be published. Required fields are marked *